戻る
Enlivex Therapeutics Ltd (ENLV)価格
ENLV 株価推移チャート
ENLV 収入
Enlivex Therapeutics Ltd
$0.94
0.66%
$0
終値： Jan 16, 16:00:00 GMT-5
$0.93
-0.71%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$0.9338
始値
$0.97
当日レンジ
$0.9331 - $0.9863
52週レンジ
$0.66 - $2.1
取引高
379.2K
平均取引高
3.9M
1株当たり利益(TTM)
-0.55
配当利回り
--
時価総額
$220.5M
ENLVとは何ですか？
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.